Related Experiment Video
Updated: Jun 10, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies
R Kadiyala1, R Peter, O E Okosieme
1Prince Charles Hospital, Cwm Taf Local Health Board, Merthyr Tydfil, UK.
International Journal of Clinical Practice
|July 21, 2010
Summary
Diabetic patients have a higher risk of thyroid dysfunction, which can worsen metabolic control and cardiovascular health. Annual thyroid screening is recommended for high-risk individuals, including those with type-1 diabetes (T1DM).
Area of Science:
- Endocrinology
- Metabolic Diseases
- Cardiovascular Health
Background:
- Patients with diabetes mellitus face an elevated risk of thyroid disease.
- Thyroid dysfunction is more prevalent in diabetic individuals, affecting up to one-third with type-1 diabetes (T1DM).
- Undiagnosed thyroid issues can compromise diabetes management and increase cardiovascular risks.
Purpose of the Study:
- To review literature on the diabetes-thyroid dysfunction association.
- To highlight clinical implications for patient care.
- To examine current thyroid screening practices in diabetes management.
Main Methods:
- Literature review of current research.
- Analysis of clinical implications.
- Evaluation of screening strategies.
Main Results:
- Thyroid hormones significantly impact metabolic processes.
- Hyperthyroidism can cause hyperglycemia; hypothyroidism may lead to hypoglycemia in diabetics.
- Thyroid dysfunction exacerbates cardiovascular risks via dyslipidemia, insulin resistance, and endothelial dysfunction.
Conclusions:
- Increased thyroid dysfunction in diabetics necessitates systematic screening.
- Annual thyroid testing should target high-risk patients, including those with T1DM, thyroid autoantibodies, or elevated TSH.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...